A detailed history of Sherbrooke Park Advisers LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 3,326 shares of BSX stock, worth $349,130. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,326
Holding current value
$349,130
% of portfolio
0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $242,664 - $279,384
3,326 New
3,326 $279 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $55,303 - $65,729
1,137 Added 5.57%
21,545 $1.25 Billion
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $940,460 - $1.02 Million
-18,738 Reduced 47.87%
20,408 $1.08 Billion
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $1.22 Million - $1.34 Million
24,446 Added 166.3%
39,146 $2.12 Billion
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $662,823 - $735,441
14,700 New
14,700 $735 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $150B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.